Stock Information
Bicycle Therapeutics PLC (BCYC)
Ticker Symbol: BCYC
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $350.31 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.1614
Revenue (TTM): $1.05 M
Dividend Yield: N/A%
ROE: -33.2%
Latest News
-
Bicycle Therapeutics Q1 EPS $(0.87) Misses $(0.73) Estimate, Sales $887.000K Miss $7.267M Estimate
Thu, Apr 30, 2026 7:25 AM
-
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
Thu, Apr 30, 2026 7:02 AM
Key Financials
Financial data not available